- Home
- LNSR vs PAVS Comparison
LNSR vs PAVS Comparison
Compare LNSR & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNSR
- PAVS
- Stock Information
- Founded
- LNSR 2004
- PAVS 2004
- Country
- LNSR United States
- PAVS United States
- Employees
- LNSR N/A
- PAVS N/A
- Industry
- LNSR Medical Electronics
- PAVS Medicinal Chemicals and Botanical Products
- Sector
- LNSR Health Care
- PAVS Health Care
- Exchange
- LNSR Nasdaq
- PAVS Nasdaq
- Market Cap
- LNSR 63.4M
- PAVS 62.6M
- IPO Year
- LNSR N/A
- PAVS 2019
- Fundamental
- Price
- LNSR $7.08
- PAVS $0.92
- Analyst Decision
- LNSR
- PAVS
- Analyst Count
- LNSR 0
- PAVS 0
- Target Price
- LNSR N/A
- PAVS N/A
- AVG Volume (30 Days)
- LNSR 43.8K
- PAVS 36.4K
- Earning Date
- LNSR 11-07-2024
- PAVS 01-09-2025
- Dividend Yield
- LNSR N/A
- PAVS N/A
- EPS Growth
- LNSR N/A
- PAVS N/A
- EPS
- LNSR N/A
- PAVS N/A
- Revenue
- LNSR $48,868,000.00
- PAVS $6,544,819.00
- Revenue This Year
- LNSR $25.07
- PAVS N/A
- Revenue Next Year
- LNSR $24.95
- PAVS N/A
- P/E Ratio
- LNSR N/A
- PAVS N/A
- Revenue Growth
- LNSR 21.29
- PAVS N/A
- 52 Week Low
- LNSR $2.10
- PAVS $0.32
- 52 Week High
- LNSR $7.96
- PAVS $2.97
- Technical
- Relative Strength Index (RSI)
- LNSR 65.23
- PAVS 54.79
- Support Level
- LNSR $6.52
- PAVS $0.89
- Resistance Level
- LNSR $7.66
- PAVS $1.00
- Average True Range (ATR)
- LNSR 0.62
- PAVS 0.06
- MACD
- LNSR 0.10
- PAVS -0.00
- Stochastic Oscillator
- LNSR 67.29
- PAVS 23.53
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.